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Summary 
In 2015, The Norwegian Environment Agency requested the Norwegian Scientific Committee 
for Food Safety (VKM) to collate an overview of bioremediation of polluted ground based on 
bioaugmentation described in literature for the degradation of various types of pollutants, 
(including hydrocarbons, heavy metals, chlorinated compounds, explosives etc.).The 
assessment of genetically modified microorganisms (GMO), phytoremediation, 
bioremediation based on natural attenuation, bio-stimulation or biodegradation, including 
composting, are not included in this report.  
For each chemical type, the Norwegian Environment Agency requested a brief description of 
the most common classes of microorganisms with respect to the properties that are relevant 
to health and environmental risk assessments. Furthermore, VKM was asked to evaluate 
whether the current information requirements in the declaration form, which importers, 
distributors or manufactures of microbiological products in Norway are required to submit, 
(cf. the Regulation on microbiological products), provide sufficient basis to assess the health 
and environmental risks involved in the use of bioremediation for the clean-up of polluted 
ground in Norway.  
VKM appointed a working group consisting of members of the Panel on Microbial Ecology. 
The Panel on Microbial Ecology has reviewed and revised the draft prepared by the working 
group, and the assessment has been adopted. 
Bioaugmentation, the focus of this report, involves supplementation of pre-grown microbial 
cultures to existing microbial population to biodegrade toxic substances to non-toxic 
substances by metabolic conversion. This technological approach is apparently cost-effective, 
more convenient and causes less environmental stress compared to conventional 
remediation approaches. However, the introduction of exogenous microbial species, strains 
or consortia to the endogenous microbial community comes with an inherent risk of 
adversely affecting the functionality of the native community and the ecosystem at large.  
The first part of this report provides an updated scientific overview of existing current 
knowledge on bioremediation with focus on bioaugmentation as a technology in 
decontaminating primarily hydrocarbons, heavy metals, halogenated compounds, and 
explosives as pollutants. The overview briefly describes the hazardous implications of 
environmental contaminants and methods for mitigating them by bioaugmentation (in situ 
and ex situ). The rationale for the use of microorganisms in remediating polluted 
environments and some microbial features utilized in bioremediation (anaerobic and aerobic 
biodegradation) are presented. Finally, possible health and environmental implications of the 
microorganisms involved are discussed. 
Based on scientific assessment of the information requirements laid down in the declaration 
form of the Regulation on microbial products, the VKM Panel concludes that the information 
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requirements in their current form are not sufficient to conduct a health and environmental 
risk assessment of added microorganisms for bioremediation of polluted ground in Norway. 
The second part of this report include specific recommendations from the working group 
concerning information needed to update the regulation on microbiological products, as 
further specified in the guidelines to the regulation for the use of microorganisms in 
bioremediation, based on initial findings.  
There seems to be a general lack of accuracy when it comes to specification of the microbial 
content and concentrations that are included in the product. Without proper taxonomic 
classification, no meaningful risk assessment is feasible. The taxonomic affiliation of the 
organisms present in the product should be specified to at least species, preferably strain 
level.  
The declaration should in our opinion not necessarily rely on specific methods, as long as the 
methods described are scientifically adequate. However, the identification should be based 
on new molecular methods, for e.g. the potential role of the microorganism in the product 
acting as a pathogen, toxigen or an allergen, its association to intestinal dysbiosis or genes 
coding for antibiotic resistance can be identified. Rather than specifying a list of specific 
antibiotics employ generic classes of antibiotics as stipulated in the Nordic Ecolabelling 
guidelines. The Panel recommends a multiphasic approach to future assessments as this 
allows for the implementation of current and most effective methods as they are developed 
and verified. 
There seems to be lack of emphasis on environmental impacts, especially on the potential for 
persistence and spread in the environment (terrestrial or aquatic), the potential for 
pathogenic effects on domestic or wild vertebrates, arthropods or plants. Furthermore, there 
is little emphasis on the effects with increased use and accumulation, persistence and spread 
in terrestrial and aquatic environments and on long-term effects on the microbial community. 
The form (vegetative, viable spores (bacteria and fungi) or cysts (protozoans)) of the 
microorganism present should be specified. If the product contains organisms that form 
endospores, spores or cysts, procedures for activating the spores or cysts and for further 
cultivation should be described. 
The declaration should provide information about the procedures and quality controls 
securing a product without contaminations, pathogens, or known relevant virulence or 
resistance factors that may increase health or environmental risks. The safety reassurances 
provided by producers of bioremediation products should also cover properties related to 
allergenicity, sensitization, plant pathogenicity and environmental impacts. How the microbes 
in the product and their pathogenic properties develop with time through and after shelf life 
should also be described. 
In our opinion, a declaration should include information about intended use and instructions 
for use, if specific precautions (personal protection, waste, containers etc.) need to be taken. 
Furthermore, information relating to user groups should be provided; for example if the 
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product is suitable for use in certain settings and environments such as areas in close 
proximity of facilities for vulnerable people (immunocompromised, infants, elderly, pregnant 
women etc.) or production animals.  
The term “Environmental Damage” is not sufficiently defined. What kinds of shift in the 
microbial community and local community can be expected in the receiving environment, 
especially if exposure is chronic and frequent? The document focuses only on the 
introduction of foreign genes into the ecosystem. The environment can also be permanently 
altered (or damaged) if the introduction of the new organisms results in the extinction of the 
naturally existing closely related species. In addition, metabolic products that might affect 
resident microbial communities could be valuable information. 
A re-evaluation of current national and international regulatory and policy frameworks may 
be necessary. This can include an evaluation of the most appropriate instruments (e.g. 
product declaration forms, regulations, standards, codes of practice, etc.) to use for 
strengthening these frameworks to mitigate risks to human health and the environment. 
 
Key words: VKM, (benefit and) risk assessment, Norwegian Scientific Committee for Food 





VKM Report 2016: 42  9 
Sammendrag  
Miljødirektoratet ga i 2015 Vitenskapskomiteen for mattrygghet (VKM) i oppdrag å utarbeide 
en litteraturoversikt over bioremediering basert på bioaugmentering for nedbryting av ulike 
typer forurensere (inkludert hydrokarboner, tungmetaller, klorinerte forbindelser, eksplosiver 
etc.). Bioremediering er en metode som brukes for å rense forurenset jord og vann ved hjelp 
av primært mikroorganismer. Bioaugmentering innebærer å tilsette pre-kultiverte mikrobielle 
kulturer til eksisterende mikrobielle populasjoner for å fremskynde nedbrytning av toksiske 
forbindelser til ikke-toksiske alternativer i forurenset jord og vann. Vurdering av 
genmodifiserte mikroorganismer (GMO), fytoremediering, bioremediering basert på naturlig 
attenuering, biostimulering eller biologisk nedbrytning, inkludert kompostering, er ikke 
inkludert i denne rapporten. 
For hver kjemikalietype ønsket Miljødirektoratet en kort beskrivelse av de vanligste klassene 
av mikroorganismer med hensyn til egenskaper som er relevante for helse- og 
miljørisikovurderinger. Videre ble VKM spurt om å vurdere om dagens krav til informasjon i 
deklarasjonsskjemaet, som den som importerer, produserer eller omsetter mikrobiologiske 
produkter i Norge er pålagt å levere, (jf. Forskrift om mikrobiologiske produkter), gir 
tilstrekkelig grunnlag for å vurdere helse- og miljørisiko ved bruk av bioremediering for 
rensing av forurenset grunn i Norge.  
VKM utpekte en arbeidsgruppe med medlemmer fra Faggruppen for mikrobiell økologi. 
Faggruppen for mikrobiell økologi har gått gjennom og revidert arbeidsgruppens utkast og 
godkjent risikovurderingen. 
Rapportens første del inneholder en oppdatert litteraturoversikt over dagens kunnskap om 
bioremediering basert på bioaugmentering. Oversikten beskriver kort konsekvenser av 
miljøforurensinger og metoder for å redusere dem ved bioaugmentering (in situ og ex situ). I 
denne delen presenteres også begrunnelsen for å bruke mikroorganismer i remediering av 
forurensede miljøer, og enkelte mikrobielle egenskaper som anvendes i bioremediering 
(anaerob og aerob biologisk nedbryting). Mulige helse- og miljøeffekter av mikroorganismene 
som benyttes er også diskutert.  
Med bakgrunn i tilgjengelig kunnskap, mener VKM at bioaugmentering ser ut til å være 
kostnadseffektiv, enklere å bruke og forårsake mindre belastning på miljøet enn 
konvensjonelle remedieringsmetoder. Imidlertid vil fremmede mikrobielle arter, stammer 
eller sammensetninger som tilsettes eksisterende mikrobielle populasjoner, kunne innebære 
risiko for at funksjonaliteten blir påvirket negativt. Det gjelder både det eksisterende 
mikrobielle samfunnet og økosystemet som helhet. 
Basert på en vitenskapelig vurdering av dagens krav til informasjon i deklarasjonsskjemaet, 
konkluderte VKMs arbeidsgruppen at kravene ikke gir tilstrekkelig grunnlag for å 
gjennomføre en vurdering av helse- og miljørisiko knyttet til mikroorganismer brukt for 
bioremediering av forurenset grunn i Norge. 
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I rapportens andre del gir VKM spesifikke anbefalinger om hva slags informasjon som er 
nødvendig for å oppdatere forskriften. 
I dagens forskrift synes det å være en generell mangel på presisjon ved spesifisering av det 
mikrobielle innholdet og konsentrasjoner i produktet. Uten en grundig klassifisering av 
mikroorganismene, er det ikke mulig å gjennomføre risikovurdering av produktet. 
Tilhørigheten til mikroorganismen i produktet bør spesifiseres til minst artsnivå, helst også 
stammenivå. 
Etter VKMs vurdering bør ikke deklarasjonen av mikrobielle produkter avhenge av spesifikke 
metoder så lenge metodene som benyttes er vitenskapelig adekvate. Identifiseringen bør 
baseres på nye molekylære metoder, f.eks. den aktuelle mikrobens potensiale som patogen, 
allergen eller toksigen, eventuelle assosiasjoner med mikrobiell ubalanse i kroppen eller 
gener som koder for antibiotikaresistens kan identifiseres. I stedet for en liste med spesifikke 
antibiotika bør det angis generiske klasser av antibiotika, på samme måte som i retningslinjer 
for Svanemerket. Det bør tilstrebes en bred metodisk tilnærming, slik at nye og mer effektive 
analyser eller evalueringsmetoder kan tas i bruk så snart de er publisert og validert. 
Dagens forskrift ser også ut til å legge liten vekt på miljøpåvirkninger av fremmede 
mikroorganismer. Det gjelder spesielt potensialet for vedvarende påvirkning og spredning av 
mikroorganismene i jord og i vann, og potensialet for å påføre ville eller tamme virveldyr, 
leddyr eller planter sykdom. Videre er det lagt liten vekt på effektene ved økt bruk og 
akkumulering, persistens og spredning både innendørs og i jord og vann, og langtidseffekter 
på det mikrobielle miljøet. 
Den aktuelle mikrobens form (vegetative, levedyktige sporer (bakterier og sopp) eller cyster 
(protozoer)), bør spesifiseres. Dersom produktet inneholder organismer som danner 
endosporer, sporer eller cyster, bør prosedyrer for aktivering og videre kultivering beskrives.  
Deklarasjonen bør også gi informasjon om prosedyrer og kvalitetskontroller som sikrer et 
produkt uten kontaminanter, patogener eller kjente relevante virulens- eller resistensfaktorer 
som kan øke risiko for helse og miljø. Sikkerhet som er angitt av produsenter av 
mikroorganismer til bioremediering, bør også dekke egenskaper relatert til allergenisitet, 
følsomhetsreaksjoner, plantepatogenitet og miljøpåvirkning. Hvordan mikrobene i produktet 
og deres sykdomsframkallende egenskaper utvikles over tid, under og etter lagring, bør også 
beskrives. 
Etter VKMs vurdering bør en deklarasjon inneholde informasjon om bruksområder og 
instruksjoner for bruk når det er behov for spesielle forholdsregler (beskyttelsesutstyr, avfall, 
emballasje osv.). 
Videre bør deklarasjonen inneholde informasjon relatert til brukergrupper. Det kan for 
eksempel være om produktet kan brukes i spesielle sammenhenger og miljøer, som arealer 
tilknyttet fasiliteter for sårbare grupper (personer med nedsatt immunforsvar, barn, eldre, 
gravide osv.), eller lokaler for produksjonsdyr. 
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Begrepet “miljøskade” er ikke tilstrekkelig definert i dagens forskrift. Hva slags endring av 
mikrobielle samfunn og miljøet lokalt kan for eksempel forventes i det eksponerte miljøet 
dersom eksponeringen er kronisk og frekvent? Dokumentet fokuserer kun på introduksjonen 
av fremmede gener i økosystemet. Miljøet kan også bli permanent påvirket eller skadet 
dersom introduksjon av en ny organisme resulterer i utryddelse av nært beslektede arter 
som finnes naturlig i miljøet. I tillegg kan det være verdifullt å få informasjon om metabolske 
produkter som kan påvirke eksisterende mikrobielle samfunn. 
En revurdering av gjeldende nasjonale og internasjonale regulatoriske og politiske 
rammeverk kan være nødvendig. Dette kan omfatte en evaluering av de mest 
hensiktsmessige virkemidlene for å styrke disse rammeverkene og redusere risiko for human 
helse og miljøet. Eksempler på virkemidler kan være produkterklæringer, forskrifter, 
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ARD Aromatic ring dioxygenases 
BAP Benzo[a]pyrene 
CFU Colony-forming units 




DDE Dichlorodiphenyldichloroethylene  
DDT Dichlorodiphenyltrichloroethane 
DNA Deoxyribonucleic acid 
DNA-SIP DNA stable isotope probing  
EC European Commission 
EEC European Economic Community 
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EPA Environmental Protection Agency 
EU European Union 
EUCAST European Committee on Antimicrobial Susceptibility Testing 
HG Mercury 
HR Hazardous rating 
IARC International Agency for Research on Cancer 
ISO International Organization for Standardization 
GMO Genetically modified organism 
MEHG Methylmercury 
NAHCO3 Sodium bicarbonate / sodium hydrogen carbonate 
NIH National Institutes of Health 
NO Nitric oxide 
OECD Organization for Economic Co-operation and Development 
PAHS Polycyclic aromatic hydrocarbons 
PCBS Polychlorinated biphenyls 
PCE Perchloroethene / Perchloroethylene 
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PFOA Perfluorooctanoic acid 
PFOS Perfluorooctane sulfonate 
TCE Trichloroethylene 
UV Ultraviolet light 
VC Vinyl chloride  
YOPI Young, old, pregnant, immune compromised 
1.2 Glossary 
Bioaugmentation - The supplementation of pre-grown microbial cultures to existing 
microbial population to enhance degradation of toxic and xenobiotic compounds in 
contaminated soil and water. 
Bioremediation - The use of organisms to degrade toxic substances to less toxic 
alternatives. 
Biostimulation - The injection of nutrients and other supplementary components to native 
microbial populations to enhance the rate of propagation and thereby stimulate the 
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Background as provided by the 
Norwegian Environment Agency 
Introduction 
 
Bioremediation is a method to remove chemical substances from contaminated soil or water. 
Bioremediation is defined by Cookson Jr (1995) as: «the application of biological treatment 
to the cleanup of hazardous chemicals by metabolic conversion into non-toxic substances”. 
According to OECD (2015) bioremediation is a cost-effective and gentle method for the 
treatment of polluted masses, compared to conventional treatment, such as excavation and 
incineration of masses or burying in specialized landfills. There are numerous examples in 
published literature documenting efforts to clean up different types of hazardous chemicals 
such as heavy metals, explosives, chlorinated compounds etc by bioremediaton. Applications 
of bioremediation vary from the household level to large-scale industrial projects. In Norway, 
field trials with bioremediation have amongst others been performed on soils contaminated 
with hydrocarbons and explosives. 
 
Three strategies of bioremediation are mentioned in the literature today; natural attenuation, 
biostimulation and bioaugmentation. This assignment is concerned with the use of 





Plans to utilize bioremediation as a treatment procedure of polluted masses are assessed 
pursuant to the Act on Protection against pollution and waste (Pollution Control Act of 13 
March 1981) and the Regulation on the limitation of pollution (Pollution regulations of 1 June 
2006 no. 931). If the bioremediation measure includes the addition of specialized organisms 
in a product, the products will be assessed as any other product under the Product Control 
Act of 6 November 1976, in addition to separate regulations of 22 January 1998 no. 93 
relating to the Declaration and labeling of microbiological products involving release to the 
environment (Regulation on microbiological products). The purpose of the Regulation on 
microbiological products is to prevent microorganisms in microbiological products from 
causing damage to health or adverse environmental effects such as disruption of 
ecosystems, pollution, or waste. According to the Regulation any person that manufactures 
or imports microbiological products or places them on the market in Norway has a duty to 
declare any information necessary for an assessment of the risk the product poses to 
damage of human health or detrimental environmental effects. The information is to be 
given in a declaration form (cf. appendix of the regulation) and amongst others include a 
description of the product and its composition, area of application, mode of use, and 
degradation products, antibiotic resistance and any pathogenic properties of the 
microorganisms. The guidelines to the regulations provide detailed description of the type of 
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information and what documentation is required in to satisfactorily declare the product. The 
information provided shall give the authorities a basis to assess the health and 
environmental risks associated with the use of the products. 
 
The Norwegian Environment Agency considers that there is a need to update according to 
current knowledge, the information requested and the methods by which this information 
has been obtained, to sufficiently evaluate the health and environmental risks of added 
microorganisms in bioremediation. The Norwegian Environment Agency also sees the need 
for an updated scientific assessment of the current knowledge regarding bioremediation of 
contaminated soil to support the current risk assessment of microorganisms in the 
bioremediation of polluted masses. 
 
Terms of reference as provided by the 
Norwegian Environment Agency 
The Norwegian Environment Agency asks VKM to: 
 
1) Collate an overview of bioremediation of polluted ground based on bioaugmentation 
described in literature for the degradation of various types of pollutants including 
hydrocarbons (including diesel, gasoline, kerosene, PAHs etc.), heavy metals, 
chlorinated compounds (PCBs), explosives etc. For each type of chemical briefly 
describe the most common microorganism classes with regards to properties relevant 
for environmental and health risk assessment (spore formation, survival, proliferation, 
pathogenicity, and more). 
2) On the basis of initial assignment and the Regulation on microbiological products, 
assess if the information requirements in the declaration form of the Regulation of 
Microbial products (and as further specified in the guidelines to the regulation) 
provide sufficient grounds to conduct a health and environmental risk assessment of 
added microorganisms for bioremediation of polluted ground in Norway. 
3) If no in section 2) assess which information requirements must / should be set in 
order to adequately risk assess added microorganisms in bioremediation of polluted 
ground focusing on (a) general requirements (b) specific requirements for classes of 
microorganisms for example if related to the degradation of specific contaminants / 
pollutants 
 
It must be considered whether the proposed information requirements may be obtained 
using internationally recognized methods available today. The assessment must include an 
evaluation of whether there is sufficient knowledge to carry out risk assessments of added 
microorganisms in bioremediation in Norway. Critical knowledge gaps for risk assessment of 
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The following is not included: 
• Assessment of genetically modified microorganisms (GMMO) are not included in the    
  assignment as they are regulated under a different set of legislation and related procedures 
• Phytoremediation is not included as it concerns the use of plants 
• Bioremediation based on natural attenuation and bio-stimulation is not included 
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Assessment 
1 Literature 
1.1 Background literature provided by the Norwegian 
Environment Agency 
Regulations of 22 January 1998 no. 93 relating to the Declaration and labeling of 
microbiological products: https://lovdata.no/dokument/SF/forskrift/1998-01-22-93 
https://www.regjeringen.no/en/dokumenter/declaration-and-labelling-of-
microbiolog/id440456/ 
Cookson, JT (1995) Bioremediation Engineering: Design and Application, McGraw Hill, New 
York 
OECD (2015) Biosafety and the Environmental Uses of Micro-Organisms: Conference 
Proceedings, OECD Publishing 
1.2 Literature searches  
The following search terms and combinations thereof were employed: Bioremediation, 
remediation biotechnology, in-situ/ex-situ bioremediation, hydrocarbons, heavy metals, 
metal pollution, petroleum pollution, bioremediation & halogen, bioremediation and halo-
organic substances, nitrogen, nitro-aromatic compounds, phosphorus, bacteria, fungi, 
aerobic/anaerobic biodegradation, bioremediation & antibiotic resistance, soil bacteria & 
resistome, health and environmental implications. 
Sources: Pubmed, oria.no, Google scholar, ISI web of knowledge, and Scopus. 
Search results were analysed for those that were of relevance. Each working group member 
performed relevance screening independently. The reference lists in selected citations were 
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2 Introduction 
Abandoned polluted areas, but also advancements in the chemical industry combined with 
increased sophistications in various technologies comes with the release of a more complex 
mixture of pollutants from production processes to end-product use and disposal into the 
environment. Consequently, remediation technologies have had to adapt to meet the 
growing demand and concern from the public and regulatory authorities towards more 
sustainable approaches concerning disposal of such toxic waste effluents. Thus, exploring 
environmental biotechnology could make significant contributions in decontaminating 
polluted environments in a sustainable manner. One such approach is bioremediation that 
employs microorganisms to biodegrade toxic substances to non-toxic substances by 
metabolic conversion. Bioremediation competes effectively with conventional approaches 
such as incineration; destruction of pollutant by combustion, solidification; encapsulation into 
cement, and thermal desorption. Presently, the petroleum, creosote, solvent and to a lesser 
extent, the pesticide industries actively employ bioremediation in their clean-up processes 
(OECD, 2015; Tyagi et al., 2011). 
Since bioremediation harnesses natural processes and low energy input is required, this 
technological approach is apparently cost-effective, more convenient and causes less 
environmental stress compared to conventional remediation approaches (OECD, 2015). 
However, there are some potential risks with the use of bioremediation in cases where the 
process may fail because of low bioavailability of the substance, or extreme toxicity in the 
microenvironment, and the partial breakdown of compounds to intermediates that are more 
toxic than the parent compound, to mention a few (OECD, 2015; Tyagi et al., 2011). With 
bioaugmentation, the focus of this report, the introduction of exogenous microbial consortia 
to the endogenous microbial community comes with an inherent risk of adversely affecting 
the functionality of the native community and the ecosystem at large (Tyagi et al., 2011).  
Most countries have thus developed guidelines or protocols for the risk assessment of the 
release of microorganisms into the environment. 
In Norway, the use of microorganisms in bioremediation as a treatment procedure of 
polluted masses are assessed pursuant to the Act on Protection against pollution and waste 
(Pollution Control Act of 13 March 1981) and the Regulation on the limitation of pollution 
(Pollution regulations of 1 June 2006 no. 931). If the bioremediation measure includes the 
addition of specialized organisms in a product, the products will be assessed as any other 
product under the Product Control Act of 6 November 1976, in addition to separate 
regulations of 22 January 1998 no. 93 relating to the Declaration and labelling of 
microbiological products involving release to the environment (Regulation on microbiological 
products). In view of these regulations, the Norwegian Environment Agency sees the need 
for updating the information requested and the methods by which such information is 
obtained, based on current knowledge in order to evaluate the health and environmental 
risks related to the use of microorganisms in bioremediation efficiently.  
 
 
VKM Report 2016: 42  20 
This report provides an updated scientific overview of existing current knowledge on 
bioremediation with focus on bioaugmentation as a technology in decontaminating primarily 
hydrocarbons, heavy metals, halogenated compounds, and explosives as pollutants. In 
addition, the report will include specific recommendations from the working committee 
concerning information needed to update the regulation on microbiological products, as 
further specified in the guidelines to the regulation for the use of microorganisms in 
bioremediation, based on initial findings. The following are not within the mandate of this 
report: 
 • Assessment of genetically modified microorganisms (these are regulated under a different  
   set of legislation and related procedures) 
• Phytoremediation is not included as it relates to the use of plants 
• Bioremediation based on natural attenuation and bio-stimulation  
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3  Hazardous implications of 
environmental contaminants 
3.1 Aromatic Hydrocarbons  
The deleterious impact of polycyclic aromatic hydrocarbons (PAHs) on human health and the 
surrounding ecosystem is due to their persistence in the environment and toxicity to the 
living component of the ecosystem. Persistence in the environment and toxicity to living 
things are linked directly to the constituent aromatic rings – number of rings and molecular 
topology or pattern of ring linkage. Persistence of PAHs, especially the high molecular weight 
PAHs (compounds with four or more aromatic rings), is generally due to size and angularity 
of the molecule (Heitkamp and 1987; Heitkamp et al., 1987; Kanaly and Harayama, 2000); 
increased size and angularity results in a concomitant increase in hydrophobicity and 
electrochemical stability (Zander, 1983; Zhang et al., 2000). Toxicity to living organisms is 
also associated with the size of PAHs. For example, PAH genotoxicity increases with 
molecular size up to at least four or five fused benzene rings (Cerniglia, 1992).  
Exposure to PAHs in the trophic web exerts acute toxicity and/or possess mutagenic, 
teratogenic, or carcinogenic properties (Kanaly and Harayama, 2000; Luch, 2009; Menzie, 
1992). For example benzo[a]pyrene (BaP) and dibenzo[a,l]pyrene (DBP), are respectively 
classified as carcinogenic (IARC Group 1) or probable (IARC Group 2) carcinogenic to human 
[http://www.iarc.fr/].  In the EU, BaP has been flagged as an environmental pollutant of 
high concern [http://echa.europa.eu/addressing-chemicals-of-concern], and has a reported 
toxicity value range of 0.22 ug/l to 1.5 ug/l in the aquatic environment 
[http://echa.europa.eu/documents/10162/13638/svhc_supdoc_pitch_publication_3296_en.p
df]. In the U.S. both BaP and DBP are considered priority pollutants (Louvado et al., 2015), 
and BP is included as 1 of 12 target compounds or groups defined in the Environmental 
Protection Agency’s strategy for controlling persistent, bioaccumulative and toxic pollutants 
(Louvado et al., 2015). In humans and animals, metabolic activation of PAHs such as BaP or 
DBP is mainly catalysed by cytochrome P450-dependent monooxygenases (CYPs) (Luch, 
2005). Studies of various carcinogenic PAHs revealed that CYP-mediated metabolism mainly 
produces the anti-diol-epoxides (Luch, 2005), which are the main DNA-binding metabolites 
that mediate the biological effects of their parent PAH compounds (Xue and Warshawsky, 
2005). 
In microorganisms, a study conducted on 16 well-known PAHs namely, napthalene, 
acenaphthene, acenaphthylene, fluorene, phenanthrene, anthracene, pyrene, fluoranthene, 
chrysene, benz[a]anthracene, benzo[k ]fluoranthene, benzo[b]fluoranthene, 
benzo[a]pyrene, benzo[ghi]perylene, dibenz[a,h]anthracene, indeno[1,2,3-cd]pyrene, 
revealed that harmful effects of the substances are largely determined by the extent to 
which a substance is partitioned between water, soil and sediment (Verbruggen, 2012). The 
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study assumes that certain effects of all 16 PAHs occur at the same concentrations in 
organisms that live in water, soil and sediment, and that they cause effects in the same way. 
It was also found that the internal effective concentration of PAHs does not differ between 
organisms in soil, water and sediment; however, large differences between the effective 
concentrations of the substances outside the organisms were observed. The harmful effects 
of the substances are thus, largely determined by the extent to which they partition between 
water, soil and sediment, and is taken up from water.  
Natural sources such as fossil fuels and anthropogenic sources in combination with global 
transport result in contamination of the environment with PAHs. Petroleum refining and 
transport activities are major contributors to localized loadings of PAHs into the environment, 
such as marine environments (Coelho, 2010; Fang et al., 2008; Guitart et al., 2007; Guitart, 
2010). However, PAHs released into the environment, such as terrestrial environments, may 
also have their sources from, for example, gasoline and diesel fuel combustion (Notar et al., 
2001). From these sources PAHs find their ways in air, soil and sediment, surface water, 
groundwater, road runoff, vegetation and food chain (Edwards, 1983; Sims, 1983).  
3.2 Heavy metals  
Heavy metals, some of which are toxic, generally refer to any relatively dense metal, and a 
few examples are given below. Metals are natural elements and constituents of the 
environment, however anthropogenic activities have altered their geochemical cycles 
rendering some of them pollutants in many cases, thus posing a threat to the environment 
and human health. Metals have been linked to birth defects, cancer, neural damage, and 
liver and kidney damage among others (WHO-IPCS, 1990; WHO-IPCS, 1992; WHO-IPCS, 
1995). For instance, lead may cause developmental neurotoxicity and impaired 
neurobehavioural functioning in children (WHO-IPCS, 1995). Furthermore, long term 
exposure to lead may cause adverse cardiovascular, effects (increased systolic blood 
pressure, associated with increased risk of cardiovascular mortality) in adults (WHO-IPCS, 
1995). Chronic kidney disease (reduction in glomerulus filtration rate) is another toxic effect 
of lead (WHO-IPCS, 1995). Regarding cadmium, well characterised chronic toxicities 
resulting from exposure are effects on kidneys and bones (WHO-IPCS, 1992). Cadmium may 
induce bone effects both by a direct effect on the bone tissue or indirectly via cadmium 
induced renal damage. Cancer is yet another chronic effect associated with cadmium 
exposure and The International Agency for Research on Cancer (IARC) has classified 
cadmium as a human carcinogen (Group 1; on the basis of occupational studies). Regarding 
mercury, different species exist (organic and inorganic). Humans may be exposed to 
methylmercury (MeHg) e.g. through the consumption of sea food, MeHg affects the 
development of the fetal brain and may cause neurologic damage in adults (Dietz et al., 
2013). In the natural environment, toothed wales (Odontoceti) appear to be a particularly 
vulnerable group, accumulating high concentrations of Hg in the central nervous system, 
leading to neurochemical effects (Dietz et al., 2013). Other adverse effects of MeHg include 
cardiovascular and reproductive effects, as well as impaired immune function (Wolfe et al., 
1998). Neurotoxic effects could also be found in of neurotoxic effects of mercury in beluga 
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whales (Delphinapterus leucas), ringed seals (Pusa hispida), and polar bears (Ursus 
maritimus) (Krey et al., 2015). 
3.3 Halo-organic substances  
Halogenated organic compounds constitute one of the largest groups of chemicals that can 
potentially pollute the environment. They have inter alia been used as  
• pesticide compounds, such as in the controversial fluorine-containing pesticide “1080” 
(Blakey) or dichlorodiphenyltrichloroethane (DDT) and its metabolites 
(dichlorodiphenyldichloroethane (DDD) and dichlorodiphenyldichloroethylene (DDE) 
(Garrison et al., 2014)   
• components of dielectric fluids, such as the forbidden polychlorinated biphenyl (PCB) 
formerly used in transformers and capacitors 
•  and flame retardants in textiles (Horrocks, 2011) 
This broad use of halo-organic substances has resulted in widespread dissemination in the 
environment (Häggblom and Bossert, 2003).  
Furthermore, are halo-organic by-products such as Tetrachlorodibenzodioxin (Thuan et al., 
2013), perfluorooctanoic acid (PFOA), surfactants, fire foams and other halogen substituents 
able to increase the hydrophobicity of organic compounds, subsequently increasing thereby 
the tendency to bioaccumulate in food chains and to sorb to soil (Mohn, 2004). Known 
examples of bioaccumulating compounds are dichlorodiphenyltrichloroethane (DDT) 
(Lukyanova et al., 2016) perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid 
(PFOA) (Baduel et al., 2014; Franklin, 2016; Perez et al., 2014; Surma et al., 2015; Wen et 
al., 2015; Zhang et al., 2015). 
3.4 Nitro-aromatic compounds 
Nitro-aromatic compounds are regarded as stable, persistent and are generally considered as 
poisonous when exposed by oral, subcutaneous, intraperitoneal or intramuscular routes. 
They exhibit human mutagenic and carcinogenic potential, and are potent uncouplers of 
oxidative- and photo-phosphorylation. Toxic fumes of NOx may be emitted during 
decomposition. All these properties render them hazardous to the environment. Therefore, 
all nitro-aromatic compounds are given hazardous rating (HR) 3, where 3 denotes the worst 
level of hazardness/toxicity (Sax and Lewis, 1999).  
The electron-withdrawing character of nitro-aromatics makes oxidative attack by oxygenase 
from aerobic bacteria difficult. The susceptibility to electrophilic attack resulting in reduction 
of nitro groups is increasing with increasing number of nitro-groups and electron 
withdrawing substituents. The result is that nitro-aromatic compounds are readily reduced to 
more reactive carcinogenic derivatives when introduced into mammalian systems. 
Epidemiological data indicate that nitro-aromatic compounds (including nitrobenzene, 
 
 
VKM Report 2016: 42  24 
dinitrotoluenes, mono- and di-nitrophenols) are powerful carcinogens, and they are 
consequently referred to as priority pollutants (EPA, 2003).  
Consequently, waste generated from mono-, di-, poly-nitro-aromatics are regulated by the 
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4 Methods for mitigating pollutants  
4.1 In situ bioremediation 
In-situ bioremediation is the use of microorganisms to degrade pollutants in place to less 
toxic products. One method of application is monitored natural attenuation, also referred to 
as intrinsic bioremediation that employs indigenous microorganisms without human 
intervention but requires site-characterization and long-term monitoring for implementation 
(OECD, 2015).  
Although emerging technologies are on the rise, bioaugmentation as well as biostimulation 
have become pivotal in in-situ bioremediation due to their complementary nature (Tyagi et 
al., 2011). Bioaugmentation, the focus of this report, involves supplementation of pre-grown 
microbial cultures to existing microbial population to enhance degradation of toxic and 
xenobiotic compounds in contaminated soil and water. Due to the complexity of most 
polluted sites, customized strategies are often required to meet specific environmental 
conditions. These include addition of pre-adapted pure strain or consortium, introduction of 
genetically engineered bacteria or relevant genes packaged into a vector among others 
(Tyagi et al., 2011). The selection of competent microbes based on microbial communities 
inhabiting target sites and use of a consortium as opposed to pure cultures have been found 
to be most effective as it provides the metabolic diversity as well as robustness needed (Nyer 
et al., 2003; Rahman et al., 2002; Tyagi et al., 2011). Additionally, the target metabolism of 
the bioremediation system depends on the contaminant of concern since some pollutants 
such as petroleum hydrocarbons are degraded aerobically whereas others take the anaerobic 
pathway and yet a third group that are biodegraded under either conditions (OECD, 2015; 
Tyagi et al., 2011). Concurrent bioaugmentation with anaerobic halorespiring and aerobic 
degrading bacteria in the remediation of polychlorinated biphenyls in contaminated sites is a 
highly efficient process achieved by the corresponding sequential halorespiratory activity that 
converts higher chlorinated congeners to lower congeners susceptible to aerobic degradation 
(Payne et al., 2013). There are, however, some drawbacks concerning the process as 
microbial inoculants are produced under controlled conditions in bioreactors and as such do 
not always survive the biotic and abiotic stresses (fluctuations and extremes in temperature, 
pH, nutrient, competition between introduced and indigenous biomass among others), when 
exposed to the complex natural habitat. The use of microbial cell encapsulation or 
immobilization provides support by controlling the flow of nutrients, lowering toxicity in the 
microenvironment and offers improved survival rates by shielding cells and enabling efficient 
biodegradation (Tyagi et al., 2011).  
Nutrient supply is essential in microbial degradation under all conditions (Horel and 
Schiewer, 2009; Tyagi et al., 2011). Injection of nutrients and other supplementary 
components such as oxygen to the native microbial population enhances the rate of 
propagation and thereby stimulates the degradation of unwanted compounds, and is 
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referred to as biostimulation. In the case of petroleum hydrocarbon spills where the carbon 
source is readily available to the existing microorganisms, addition of nitrogen and 
phosphorus, the rate-limiting nutrients substantially improves the degradation process and 
thus the decontamination rate. In some contamination sites, there has been need for the 
concurrent application of biostimulation as well as bioaugmentation to produce synergistic 
effects (Tyagi et al., 2011). These two techniques are thus complementary rather than 
competing. 
The primary function of fungi in ecosystems is that of decomposition, by nature. 
Mycoremediation refers to the deliberate use of fungi to degrade contaminants. Bioventing, 
biosparging and bioslurping are various in situ remediation technologies that have evolved to 
meet specific environmental conditions related to groundwater and employ additives like 
oxygen in order to facilitate the degradation process.  
It is worth noting that phytoremediation (excluded from this assessment) involves the use of 
plants to remediate based on their ability to remove, transfer, concentrate or metabolize 
elements by various processes influenced by their roots, is particularly useful in mitigating 
heavy metal pollutants ((EPA, 2006), see section 4.4 for details). 
4.2 Ex situ bioremediation 
As its name implies, ex situ bioremediation usually involves removal by excavation or 
extraction and transportation of contaminants or waste to process site for treatment and can 
simply be classified by the physical state of the contaminated material for which the 
application is required, namely, solid-phase, liquid-phase and slurry-phase bioremediation 
(EPA, 2006).  
Solid-phase bioremediation utilizes an aboveground treatment center. The most common 
treatments for solids are biopiles, land farming and composting (EPA, 2006). Land farming is 
a simple process in which the excavated soil is spread over a characteristic pad with the 
capacity to collect any residual fluid from the soil, which is then turned regularly to allow 
transport of oxygen and thereby enhance the degradation process of endogenous microbes 
(Rittmann et al., 2001). Soil biopiles involves a collection area equipped with an aeration 
system/vacuum pump that allows oxygen to readily reach the existing microbial community 
and potentially suck up volatile contaminants. These are typically 2-3 m high and to 
stimulate degradation, environmental conditions such as moisture, pH, temperature, 
nutrients are controlled (EPA, 2006). In composting the soil is mixed with organic wastes and 
bulking agents such as straw or corncobs to enhance porosity and thereby degradation.  
Treatment of solid-liquid mixtures such as sludge wastes and slurries employs bioreactors 
among others. Constructed wetlands that involve the biological assimilation, breakdown and 
transformation of pollutants are commonly used for liquids (EPA, 2006). Concurrent 
applications of bioaugmentation or phytoremediation are usually employed.  
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Taken together, in-situ bioremediation is considered simpler and convenient but long-term 
whereas ex-situ bioremediations are short-term but inconvenient due to the need for 
excavation or extraction, and transportation in some cases. Generally, these processes, with 
their inherent benefits as well as drawbacks are adapted for specific situations. 
4.3 Polycyclic Aromatic Hydrocarbons  
Apart from the use of microorganisms, PAHs can also be removed from polluted 
environments by chemical methods, thermal methods and UV light irradiation. UV light 
technology has been used in PAH removal from solid matrices such as soil and sludge (Dong 
et al., 2010),(Zhang et al., 2008). UV rays cause photodegradation of PAHs by breaking the 
benzene ring in PAH’s structure in the presence of radicals (Zhang et al., 2008),(Guieysse et 
al., 2004). Titanium oxide, methyl orange and ammonium chloride are examples of catalysts 
that can aid photodegradation of PAHs by UV light (Zhang et al., 2008). 
In the chemical method, the two most commonly applied techniques to clean up PAH 
contaminated sites are soil washing by water and solvent (polar) extraction. The main factor 
which governs the efficiency of this process is the solubility of PAHs in the extraction solvent. 
These two approaches are however inefficient, toxic and expensive, especially with respect 
to removal of high molecular PAHs. Various alternative extraction agents are being studied, 
including surfactants, biosurfactants, microemulsions, natural surfactants, cyclodextrins, 
vegetable oil and solution with solid phase particles. These extraction agents have been 
found to remove PAHs from soil at percentages ranging from 47 to 100% for various PAHs 
(Lau et al., 2014), but information on the toxicity of these approaches is lacking. 
Thermal treatment (indirect heating) is also used in the removal of PAHs, especially from 
petroleum sludge, which contains high level of high molecular weight hydrocarbons. In most 
thermal treatments, degradation of PAHs is achieved at temperature range of 250oC – 650oC 
using Ca(OH)2 + NaHCO3 as an additive (Pakpahan et al., 2013). However, high 
temperatures used for this treatment cause the modification of PAH structure, such as 
intramolecular rearrangement and molecular weight growth by acetylene addition. These 
contribute to the presence of residual PAH in the resultant biochars, sometimes in 
concentrations above the recommended safe levels (Pakpahan et al., 2013). 
4.4 Heavy metals  
Conventional methods for removal of metals from soil or water include for instance land 
filling (excavation, transport and deposition of contaminated soil), fixation (chemical 
processing of soil to immobilize the metals in soil, often followed by measures to prevent 
penetration by water), leaching (applying acid solutions to desorb and leach metals from 
soil), precipitation or flocculation (in water) followed by sedimentation and disposal of 
sludge, ion exchange (in water), reverse osmosis (in water), microfiltration (of water), 
electrodialysis (of water), and evaporation (Wise et al., 2000).  
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Bioremediation measures against metal pollution may include different mechanisms. 
Microbes may be used to covert metals into non-toxic forms. The process may involve 
oxidation, binding, immobilization, volatilization, or transformation. It must be pointed out 
that the metals are elements and thus cannot be degraded; however, remedial processes 
transform their oxidation state or organic complex (Wise et al., 2000).  
Phytoremediation (not assessed here) is another bioremediation measure and refers to the 
use of plants and associated microorganisms to remove specific contaminants from soil, 
sludge, sediments or water. Phytoremediation may also include different processes, including 
phytoextraction (uptake of contaminants from soil or water by plant roots and translocation 
into biomass), phytofiltration (adsorption to e.g. roots to minimize movement in water), 
phytostabilization (reduction of mobility and bioavailability to prevent migration to water or 
the food chain) and phytovolatilization (e.g. absorption of metals by plants, followed by 
conversion into volatile forms that are released to the atmosphere). 
4.5 Halo-organics  
Halo-organic compounds are not easy degradable by nature. Technically possible, but often 
non-economic, in situ remediation methods for halo-organic contaminants include i.a. and 
often in combination:  
• Thermal remediation, such as the use of microwave remediation of hexachlorobenzene 
treated soil (Calvert and Suib, 2007) 
• Chemical remediation, such as the use of zero-valent iron against chlorinated 
hydrocarbon compounds via reductive dehalogenation (Gillham and O'Hannesin, 1994) 
• Physical remediation, such as by soil vapour extraction (Albergaria et al., 2012) 
Phytoremediation is also for halo-organic compounds increasingly used. Plants remediate halo-
organic compounds by phytotransformation (metabolic conversion), phytostabilisation or by 
supporting microbial bioremediation. Examples for phytoremediation include the use of poplar 
trees in remediation of trichloroethylene (TCE) (Gordon et al., 1998) or  Echinacea purpurea 
against polycyclic aromatic hydrocarbons (PAHs) (Liu et al., 2015). 
Microbial bioremediation of halo-organics in a stand-alone approach is difficult, as the 
potential for bioremediation requires that a halo-organic compound can be biodegraded, 
partly or completely destroyed by metabolism. 
4.6 Nitro-aromatics 
The reduction of nitro-groups to nitroso derivatives, hydroxylamines or amines is catalyzed 
by nitroreductases. Anaerobic transformation of nitro-aromatics by reduction of nitro groups 
to aromatic amines is receiving increased attention (Razo-Flores et al., 1997). It has been 
shown that most of the poly-nitro-aromatics are susceptible to degradation only under 
anaerobic conditions (Nishino and Spain, 2002; Zhang and Bennett, 2005). However, single 
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species of anaerobes are rarely capable of complete conversion of nitro-aromatic substrate 
to CO2 or methane (Razo-Flores et al., 1997). Thus, synergistic effort of a consortium of 
microbes is required for complete as well as partial degradation of several compounds, as 
e.g. dinitrotoluene, 3,5-dinitrobenzoic acid, 2-, 3- and 4-nitrophenol or TNT (Alexander, 
1999; Hess et al., 1990).  
The rate of reduction of nitro compounds is determined by the chemical properties of the 
entire molecule, i.e. number of rings, number and types of substituents. Several different 
pathways are postulated for degradation of a wide range of nitro-aromatics, involving 
complex systems of bacterial and fungal extra-cellular non-specific enzymes. 
Anaerobic bacteria reported to perform biodegenerating effects on common nitro-aromatics 
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5 Rationale for the use of 
microorganisms in remediating 
polluted environments  
Hazardous pollutants are frequently introduced and thereby pollute the environment despite 
attempts by various countries to prohibit or reduce this through regulations. Being 
recalcitrant, the pollutants can persist and accumulate in the environment if not removed. 
Therefore, efficient ways to remove or convert them into forms that are harmless or 
utilizable in the ecosystem are required and being steadily developed. Microorganisms are 
found everywhere, can adapt to most environmental conditions and possess inherent abilities 
to metabolize most compounds and utilize them as energy sources or bio-convert them into 
forms that can easily be absorbed and/or utilized by other life forms in the ecosystem. This 
ubiquity, versatility, malleability and adaptability makes microorganisms and lower plant 
forms efficient agents of bioremediation. For example, bioremediation can be applied to 
areas that are not accessible without excavation, e.g. in the remediation of groundwater 
contamination, which is cost effective. Moreover, advances in microbial culture techniques, 
genome sequencing, genetic engineering and ‘omics’ are providing unprecedented insights 
into different biochemical pathways, regulatory networks to carbon flux in particular 
environments and particular compounds, and molecular adaptation strategies to changing 
environmental conditions. These have enabled the identification and engineering of 
organisms, which can be utilized in the remediation of contaminated extreme environments. 
Thus, identified bioremediation-useful genes of some extremophiles can be engineered into 
other microorganisms (or vice versa) (Brim et al., 2000); the microorganisms are 
subsequently ‘trained’   and used to remediate contaminated sites.  
Justification for the use of microorganisms to remove polluting hazardous substances, similar 
to other biotechnological fields employing microorganisms, is the safety and efficiency of the 
process. Unlike chemical remediation of environmental pollutants whose products in 
themselves can constitute environmental hazards, and can be injurious to resident 
indigenous microorganisms, the final products of bioremediation are the environmentally 
benign compounds of fatty acids, CO2, NH4+ or H2O, while the intermediate by-products are 
usually energy sources for other organisms. However, some intermediate metabolic products 
can be toxic (Podar et al., 2015). Vinyl chloride, a partially dehalogenated analog of 
tetrachloroethane, is a known carcinogen (Delgado et al., 2014; Holmes et al., 2006; McCue 
et al., 2003; Nielsen and Keasling, 1999). Nonetheless, it is not impossible to discover or 
engineer microbial life forms that can metabolize and thus remediate such toxic 
intermediates (Brim et al., 2000). 
Application of microorganisms as bioremediators is not without some risks given that some 
microorganisms are agents of diseases. This has informed the use of non-pathogenic strains 
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in bioremediations. In addition, potential pathogenic genes can be identified and removed 
from the genomes of bioremediators with high promise through genetic engineering 
techniques. For specially engineered or where non-indigenous microorganisms are applied to 
particular sites, once the contaminants are completely metabolized or removed, their food 
chain is cut-off and the microbes should theoretically die and become food sources 
themselves for aquatic and terrestrial organisms. However, there are exceptions where the 
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6 Microbial features utilized in 
Bioremediation 
The diversity of microorganisms that can potentially be used for remediation purposes is 
huge. Some important microbial features utilized in bioremediation are described below.  
However, properties relevant for environmental and health risk assessment (spore formation, 
survival, proliferation, pathogenicity etc.) for such a vast variety of microorganisms would be 




 Polycyclic Aromatic Hydrocarbon Bioremediation 
 
There is a substantial body of literature highlighting the great diversity in microbes (bacteria 
and fungi; fungi is described in a later section) that are capable of degrading PAHs. For 
example at the time of writing this report, a PubMed search with the string ‘Bioremediation, 
Aromatic hydrocarbon, Bacteria’ returned 6218 hits. These microbes harbour different and 
often interconnected pathways required to achieve the bioremediation of sites contaminated 
with PAHs and other co-occurring contaminants. Several review articles have summarized 
bacteria involved in PAH biodegradation, for example (Bressler and Fedorak, 2000; Cerniglia, 
1984; Cerniglia, 1997; Diaz and Prieto, 2000; Dua et al., 2002; Fernandez-Luqueno et al., 
2011; Giessing and Johnsen, 2005; Johnsen and Karlson, 2005; Johnsen et al., 2005; Kanaly 
et al., 2000; Meckenstock et al., 2004; Samanta et al., 2002; Watanabe, 2001; Zylstra et al., 
1997). The bacteria described in these articles were isolated based on the traditional 
isolation methods and pure culture studies of their PAH degrading abilities. The most recent 
reviews (Aranda, 2016; Castillo-Carvajal et al., 2014; El Amrani et al., 2015; Fuentes et al., 
2014; Jeon and Madsen, 2013; Louvado et al., 2015; Vila et al., 2015) also included more 
modern identification methods some of which do not require isolation and culture of the 
bacterial species. Although bacterial activities in PAH degradation are known to be distinct in 
both terrestrial and aquatic environments, this report focused on bacteria associated with 
PAH degradation in terrestrial environments. A historical approach in chronicling common 
PAH degrading bacteria genera has been adopted. This highlights different technological 
advancements that enabled the bacterial identification in PAH degradation. 
In published articles leading up to the year 2000 (see also review by Kanaly and Harayama 
(2000)), the usual bacterial culprits in soil PAH biodegradation include species in the genera 
Pseudomonas (Barnsley, 1975), Sphingomonas (Khan et al., 1996), Alcaligenes (Weissenfels, 
1991), Mycobacterium (Kelley, 1995), Rhodococcus (Walter, 1991), Gordona (Kästner, 
1994), Flavobacterium (Trzesicka-Mlynarz and Ward, 1995), Cycloclasticus (Geiselbrecht et 
al., 1998), Burkholderia (Juhasz, 1997). Studies in the identification of bacteria in PAH 
degradation were mainly by isolation, pure culture and single substrate incubation.  
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The years 2000 to 2010 witnessed multiple substrate incubation, mixed bacteria culture and 
the use of molecular techniques such as PCR and pyrosequencing in studies related to 
bacteria PAH degradation. During this time frame, additional new species were described in 
association with PAH degradation. These belong, predominantly, to the genera 
Achromobacter (Wang, 2008), Acinetobacter (Nwanna, 2006), Aeromonas (Saagua, 2002), 
Aquamicrobium  (Andreoni et al., 2004), Arthrobacter (Lors et al., 2004), Bacillus (Hori, 
2000), Brevibacterium (Farahat, 2008), Comamonas (Widada et al., 2002), Corynebacterium 
(Lors, Tiffreau et al. 2004) (Lors et al., 2004), Methylobacterium (Andreoni et al., 2004), 
Micrococcus (Hori, 2000), Moraxella (Samanta et al., 2001), Rhizobium (Andreoni et al., 
2004), Stenotrophomonas (Andreoni et al., 2004), and Staphylococcus (Mallick et al., 2007).  
Using a combination of substrate enrichment, co-incubation, and the advanced techniques of 
‘omics’, DNA stable isotope probing (DNA-SIP) technology, deep sequencing and 
pyrosequencing between 2010 and 2016, additional genera were added to the list of PAH 
degrading bacteria. For example, Cupriavidus and Luteimonas were recently identified in 
degradation of PAH in PAH-polluted soil (Jones et al., 2014). Another genus which has not 
previously been associated with PAH degradation, namely Hydrogenophaga, was the most 
abundant components of a pyrene-degrading consortium that were identified from soil 
contaminated with high molecular weight polycyclic aromatic hydrocarbons (Sun et al., 
2010). Further, several new bacteria genera, namely, Acidovorax, Rhodoferax, 
Pigmentiphaga and Hydrogenophaga, were added to the list of PAH degrading bacteria from 
studies that employed the DNA-SIP technology in early response to PAH degradation 
(Cebron et al., 2011; Jones et al., 2011; Martin et al., 2012; Singleton et al., 2006). Also, 
some yet-to-be cultured members of Proteobacteria were revealed to be relevant in the 
biodegradation of anthracene and pyrene (Jones et al., 2011; Singleton et al., 2006), 
although their abundance was simulated by barcoded pyrosequencing (Singleton et al., 
2013; Singleton et al., 2011).  
 Halo-organic substances 
Microorganisms have evolved a variety of metabolic strategies for cleaving the carbon-
halogen bond. Chloroorganic aliphatic and aromatic compounds serve for those bacteria as 
carbon and energy sources, or as terminal electron acceptors (Smidt and de Vos, 2004; 
Zanaroli et al., 2015). The range of biologically-mediated dehalogenation reactions and 
processes are summarized in a number of reviews (El Fantroussi et al., 1998; Erable et al., 
2005; Ewald et al., 2007; Fetzner, 1998; Haggblom, 1992; Hardman, 1991; Janssen et al., 
1994; Kurihara and Esaki, 2008; Li et al., 2010; Maltseva et al., 1999; Olaniran et al., 2004; 
Reineke and Knackmuss, 1988; Smidt and de Vos, 2004; Zanaroli et al., 2015). Häggblom 
and Bossert (Häggblom and Bossert, 2003) provide a brief overview of aerobic and anaerobic 
microorganisms, and their abilities to metabolize halogenated organic compounds. 




VKM Report 2016: 42  34 
• Desulfitobacterium (Renpenning et al., 2015; Smidt and de Vos, 2004; Wiegel et al., 
1999; Zanaroli et al., 2015) 
• Clostridium (Li et al., 2015; Lütke-Eversloh, 2014) 
• Spirochaeta (Kaufhold et al., 2013; Vandermeeren et al., 2014) 
• Sedimentibacter (Jugder et al., 2015; Justicia-Leon, 2012; Maphosa et al., 2012) 
• Pseudomonas (Hamid et al., 2013; Kaur and Parihar, 2014; Maphosa, 2010) 
• Burkholderia (Dobslaw and Engesser, 2015; Löffler et al., 2013; Su et al., 2013) 
It is important to stress that the diversity of bacteria able for biologically-mediated 





Even if the literature on mycoremediation is less comprehensive than for bacteria, there still 
is a substantial body of literature highlighting the great diversity. The search string ‘Soil, 
Bioremediation, Fungi’ returned 457 hits from the last 5 years in PubMed. Bacteria are more 
commonly used in bioremediation, but fungal mycelia exhibit the robustness of adapting to 
highly restrictive environmental conditions often experienced in the presence of persistent 
pollutants, which makes them more useful compared to other microbes (Chanda et al., 
2016). Fungi hold in general a broad spectrum of biodegrading enzymes, and both 
mushrooms, (toxigenic) filamentous fungi and yeasts have been shown to have effect when 
used in bioremediation of various pollutants as eg. PAHs, nitro-aromatic compounds, 
chlorinated substances, and heavy metals (Singh, 2006). As an example are white-rot fungi 
considered effective in degrading a wide range of organic molecules due to their release of 
extra-cellular lignin-modifying enzymes with a low substrate-specificity. They can therefore 
act upon various molecules that are broadly similar to lignin. The enzymes present in the 
system employed for degrading lignin include lignin-peroxidase (LiP), manganese peroxidase 
(MnP), various H2O2 producing enzymes and laccase (Singh, 2006).   
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7  Anaerobic biodegradation 
7.1  Aromatic Hydrocarbons 
In contrast to aerobic biodegradation of PAH (discussed in Section 8.1), information on 
anaerobic PAH degradation is limited. Aerobic PAH degradation in contaminated sites will 
lead to oxygen depletion resulting in an anaerobic or microaerobic environment. In such 
environments with decreased redox potential, denitrifying, sulphate-reducing and 
methanogenic bacteria become the dominant players in PAH degradation (Riser-Roberts, 
1998), (Christensen et al., 2004) (al-Bashir et al., 1990), (Meckenstock, 1999), (Rockne et 
al., 2000). Bacteria anaerobic biodegradation of PAH is slow, however its ecological 
significance in terms of the impacts of intermediate breakdown products is relevant.   
7.2  Heavy metals 
With regards to metals, all forms of degradation (hereby anaerobic) are not 
applicable/relevant since metals as elements are not broken down per se. 
7.3  Halo-organic substances 
Anaerobic processes for halo-organics compounds has been applied for products like 
• Chlorinated solvents such as PCE, TCE, TCA, DCA, CCl4, chloroform and methylene 
chloride (Backhus et al., 1997; Doong and Chang, 2000) 
• Chlorobenzenes including di- and tri-chlorobenzene (Adrian and Görisch, 2002) 
• Most pesticides including DDT, DDE, dieldrin, 2,4-D and 2,4,5-T (Baczynski et al., 
2010) 
7.4  Nitro-aromatic compounds 
The reduction of nitro-groups to nitroso derivatives, hydroxylamines or amines is catalyzed 
by nitroreductases. Anaerobic transformation of nitro-aromatics by reduction of nitro groups 
to aromatic amines is receiving increased attention (Razo-Flores et al., 1997). It has been 
shown that most of the poly-nitro-aromatics are susceptible to degradation only under 
anaerobic conditions (Nishino and Spain, 2002; Zhang and Bennett, 2005). However, single 
species of anaerobes are rarely capable of complete conversion of nitro-aromatic substrate 
to CO2 or methane (Razo-Flores et al., 1997). Thus, synergistic effort of a consortium of 
microbes is required for complete as well as partial degradation of several compounds, as 
e.g. dinitrotoluene, 3,5-dinitrobenzoic acid, 2-, 3- and 4-nitrophenol, TNT (Alexander, 1999; 
Hess et al., 1990).  
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The rate of reduction of nitro compounds is determined by the chemical properties of the 
entire molecule, i.e. number of rings, number and types of substituents. Several different 
pathways are postulated for degradation of a wide range of nitro-aromatics, involving 
complex systems of bacterial and fungal extra-cellular non-specific enzymes. 
Anaerobic bacteria reported to perform biodegenerating effects on common nitro-aromatics 
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8 Aerobic biodegradation 
8.1  Aromatic Hydrocarbons 
The initial step in the aerobic catabolism of a PAH molecule is the oxidation of the PAH to a 
metabolite with one or two –OH radicals; this is catalysed by the aromatic ring dioxygenases 
(ARD) and di- or monooxygenases (Demaneche et al., 2004; Kanaly and Harayama, 2000; 
Seo, 2009). In soil, the diversity of genes encoding ARD among PAH-degrading bacteria has 
been clustered into two groups associated with Gram-positive and Gram-negative bacteria 
(Cebron et al., 2008). Following oxygenation, the dihydrodiol intermediate ring structure is 
cleaved to protocatechute and catechol catalysed by intradiol- or extradiol oxygenases 
(Finette et al., 1984; Schocken and Gibson, 1984). The protocatechute and catechol are 
further converted to tricarboxylic acid cycle intermediates (Jiménez, 2004; Nzila, 2013; Seo, 
2009).  
8.2  Heavy metals 
With regards to metals, all forms of degradation (in this instance aerobic) are not applicable 
/relevant since metals as elements are not broken down per se. 
8.3  Halo-organic substances 
Aerobic bioremediation typically proceeds through oxidative processes to render the 
contaminant either partially oxidized to less toxic by-products or to fully oxidize the 
contaminants. Aerobic culture techniques are relatively simple compared with anaerobic 
culture methods. Furthermore, are aerobic processes considered the most efficient and 
generally applicable.  
Literature about aerobic bioremediation for halo-organic-substances is not extensive. One of 
the few published examples is the bioremediation of 1,2 dichloroethane (1,2 DCA) and vinyl 
chloride (VC) (Davis et al., 2009). 
8.4  Nitro-aromatic compounds 
Degradation of nitro-aromatic compounds by aerobic bacteria and fungi involves mainly 
mono- and di-nitro-aromatics as a source of carbon and/or nitrogen and energy by complete 
mineralization. During the past few decades has various microbes which degrade/mineralize 
nitro-aromatics aerobically been identified (Table 1, see appendix I), and the catabolic 
pathways and enzymes involved in aerobic degradation processes have been elucidated. 
The main degeneration reactions are: 
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1. Monooxygenase catalyzed reactions 
Monooxygenase adds a single oxygen atom and causes elimination of nitro groups 
from mono-nitrophenols.  
 
2. Dioxygenase catalyzed reactions 
Dioxygenase introduces two hydroxyl groups with the removal of a nitro group as 
nitrite from the aromatic ring.  
 
3. Meisenheimer complex formation 
The partial reduction of the aromatic ring of di- or tri- nitro-compounds through 
addition of hydride ions leads to formation of a hydride-Meisenheimer complex 
(Spain, 1995).  
 
4. Partial reduction of aromatic ring 
The nitro group is partially reduced to corresponding hydroxylamine and upon 
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9 Possible health and environmental 
implications of the microorganisms 
involved  
9.1 Possible unwanted/unintended effects of bioremediation 
The products or by-products of microbial bioremediation may potentially be even more 
persistent or toxic than the original contaminant, in addition is the real environment that 
contains contaminants mixed, unevenly distributed, and in different phases (solid, liquid, 
gas), which may lead to unexpected outcomes. Long-term studies regarding the effects of 
bioremediation are not known to the authors. Possible risks include spread of pathogens, 
transmission of antimicrobial-resistance genes and production of biological toxins (see 
section 10 for details on the recommendations to the regulation on microbial products and its 
guidelines). 
The emergence and spread of antibiotic-resistant bacteria has accelerated the recent years, 
leading to problems in the treatment of infectious disease caused by bacteria (Rossolini et 
al., 2014; Ventola, 2015). The development of antibiotic resistance is a natural phenomenon, 
based on Darwinian principles. The genes for antibacterial resistance can be passed from 
one generation of bacteria to the next (vertically) and between bacteria of the same 
generation and bacteria of different species (horizontal gene transfer) (Furuya and Lowy, 
2006).  
 Bacteria 
9.1.1.1  Hydrocarbons 
The intermediate aerobic PAH degradation products and enzymes are similar to those of 
other metabolic pathways and are widespread among bacteria (de Lorenzo, 2008). Thus, 
metabolic intermediates of bacterial PAH degradation have not been associated to any 
toxicity, but transient toxicity of the early intermediates during product breakdown, (in soil 
the estimated half-lives of 3-ring phenanthrene and 5-ring benzo[a]pyrene range from 16 to 
126 days and 229 to 1400 days respectively (Peng, 2008; Shuttleworth and Cerniglia, 1995), 
cannot entirely be ruled out. In anaerobic and microaerobic environments, such as deep sea 
sediments however, many intermediates currently lack analytical confirmation, and may 
harbour unknown metabolic pathways. For example, the main metabolite in deep sea 
sediments, cyclopenta(def)phenanthrone, has not yet been detected in pyrene degradation 
pathways in the available literature (Louvado et al., 2015).  
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There is limited information in relation to the health implications of the inherent properties of 
bacteria commonly used in PAH degradation, but pathogenic bacteria species, in general, are 
not employed in PAH degradation. Nonetheless, acquisition and/or transfer of potential 
pathogenic genes, such as antibiotic resistant genes, between degrading and resident 
bacteria cannot be excluded.  
9.1.1.2  Heavy metals 
Mercury (Hg) is a potentially toxic element that enters the biosphere from natural and 
anthropogenic sources. Anoxic conditions favour the bacterial transformation of inorganic Hg 
to methylmercury (MeHg). Methylmercury is the most toxic form of Hg and has a greater 
potential for bioaccumulation than inorganic Hg. With the exception of a few syntrophic and 
fermentative firmicutes, Hg methylators are heterotrophic bacteria that use sulphate iron and 
CO2 as terminal electron acceptors. The capability of Hg methylation can be predicted by the 
presence of the hgcAB genes (Podar et al., 2015). Desulfovibrio sp. and Geobacter are 
examples of known mercury methylating bacteria. 
Podar et al. (2015) found that microbial systems engineered for degradation of chlorinated 
compounds often contained abundant hgcAB, and pointed out that the MeHg formation 
potential of dechlorinating systems is consistent with the dechlorinating capacity of some 
methylating Deltaproteobacteria and Clostridia, but may also be linked to the presence of 
hgcAC in some Dehalococcoides. 
This suggests that there may be a potential for rendering mercury more toxic if 
contaminated sites are treated with certain microbes to facilitate degradation of 
organohalides. 
Analogue issues may theoretically apply for other metals. For instance, arsenite, As(III) is 
more mobile and toxic than Aresenate As(V), and a wide varity of bacteria known as As(V)-
resistant microbes can reduce As(V) (listed by Yamamura and Amachi (2014).  
It is also known that hexavalent chromium, Cr(VI), is toxic, carcinogenic and mobile, while 
trivalent chromium, Cr(III), is less toxic and less mobile. Murray et al. (2005) showed for 
instance that microorganisms may indirectly mediate Cr(III) oxidation, as Pseudomonas 
putida strain GB-1 can rapidly oxidize Cr(III) in the presence of Mn(II). The diverse 
metabolism of wild-type strains of P. putida may potentially be used for bioremediation, as it 
for example has been shown in the laboratory to function as a soil inoculant to remedy 
naphthalene-contaminated soils (Gomes et al., 2005).  
9.1.1.3  Halo-organic substances 
Some partially biodegraded/dehalogenated metabolites can be more harmful than the initial 
compound, both with regard to intrinsic toxicity as well as mobility in the environment. For 
instance, vinyl chloride (VC), a volatile, toxic metabolic product and a known carcinogen, is a 
partially dehalogenated analog of tetrachloroethene PCE and TCE (Delgado et al., 2014; 
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Holmes et al., 2006; McCue et al., 2003; Nielsen and Keasling, 1999). Another example is DDE 
[1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene], a major environmental transformation product 
of DDT [1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane], which is a more potent androgen 
receptor antagonist than its parent compound (Kelce et al., 1995). Moreover, products of 
microbial reductive dechlorination of polychlorinated biphenyls (PCBs) are more effective than 
parent PCB mixtures at stimulating uterine contractions in vitro (Tsuneta et al., 2008). 
A publication from 2005 (Ganey and Boyd, 2005) notices that issues of bioavailability are not 
considered when performing in vitro toxicity assays. Furthermore not only should the toxicity 
of the parent contaminants be tested, their stable transformation products produced during 
remediation should be tested as well. This includes bioavailability from an environmental 
engineering point of view (e.g., how much of the contaminant is not bound to soil constituents) 
and from the perspective of toxicology (e.g., how much of the exposure dose interacts with 
target tissue). According to the authors can those issues best be addressed using whole-
organism studies (Ganey and Boyd, 2005). In addition, biologically based toxicokinetic and 
toxicodynamic modelling could be used to address issues of extrapolation to human risk. 
 Fungi 
Filamentous fungi that produce mycotoxins also demonstrate the ability to degrade a wide 
variety of naturally occurring and anthropogenically generated hazardous wastes. Hence, 
these are emerging as excellent candidates for bioremediation. However, it appears that 
several regulatory factors that govern mycotoxin synthesis in these toxigenic strains also 
regulate their bioremediation abilities. More research is needed before the full potential of 
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10 Evaluation and recommendations to 
improve the guidelines for the 
regulation on microbiological 
products  
This chapter has been jointly written together with the working group on “Health and 
environmental risk assessment of microbial cleaning products” and subsequently specified for 
bioremediation.   
The guidelines to the regulation of 22 January 1998 no. 93 on the declaration and labeling of 
microbiological products consists of 9 main parts with a total of 28 specific questions, 
outlined accordingly as separate sections below 
[https://www.regjeringen.no/en/dokumenter/declaration-and-labelling-of-
microbiolog/id440456/]. 
Although the guidelines require extensive documentation of bioremediation products, the 
Panel still considers that there is need for further information and above all a general 
modernization in the methodological approach. This is discussed in more detail below.  
 
10.1 General information 
 
Part 1 of the declaration (questions 1-9) and the guidelines is generally 
satisfactory in the current form. However, the contact details (e.g. web address) should 
be updated and the data sheet following the product (or another documentation stating its 
trade name) should be provided. 
 
10.2 Composition of the product 
 
Purpose of Part 2: To identify all components of the product, both 
microorganisms and chemical components. 
 
This part needs to be re-evaluated in order to provide more accurate 
requirements for specification of the microbial and chemical composition of the 
product.  
 
Question 10. Specify which microorganisms are present in the product. 
An accurate identification of the microorganisms present in the product is crucial for a proper 
risk assessment. Allowing a specification to genus-level, will likely both increase the risk for 
allowing the incorporation of unknown pathogenic microorganisms in the product, and will 
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likely increase the risk for eventual horizontal transfer of AB resistance genes from resistant 
conspecifics. The taxonomic affiliation of the organisms present in the product should 
consequently be specified to at least species, preferably strain level. The identification could 
be e.g. 16 S ribosomal DNA or similar specific methods. A list of suitable methods is provided 
in Table 1, (p. 927) in (Emerson et al., 2008).  
Concern for antibiotic (AB) resistance: Rather than specifying that the microorganism shall 
not be resistant to a specific list of antibiotics, we recommend that the regulation specifies 
the classes of antibiotics to which the organisms shall not be resistant to. AB resistance is 
partly due to mutations, and partly due to horizontal gene transfer. Some of the resistance 
mechanisms are generic, and highly transferable, and focus on the classes of AB will address 
this issue better.  
This area also would benefit from the new molecular genetical methods, where genes coding 
for AB resistance can be identified (McArthur et al., 2013). 
An overarching improvement in quality assurance of the data would be to specify that the 
laboratories providing the necessary data, are accredited to the relevant ISO-standard.  
Question 11. Specify the concentration(s) of the microorganism(s) present in the 
product itself.  
The concentration of the microorganism(s) in the undiluted product and the anticipated end-
user dilution must be provided. CFU enumeration is one option, but may miss strains 
growing poorly on standard agar counting plates. Currently more powerful microscopical and 
flow cytometer based methods are developed for a number of applications. Some of these 
allows specification of metabolically active vs passive cells. “Best practice” for documentation 
of concentration must be used, and documentation of the choice of method must be given.  
Question 12. Specify the chemical substances present: CAS no., chemical name, 
EC number, classification, content as percentage by weight. 
The Panel on Microbial Ecology consider that these issues are fairly well covered by existing 
regulations. The Panel has no further comments to this question. 
10.3 Information on any pathogenic properties of the 
microorganisms 
 
Purpose of Part 3: to obtain information on any pathogenic properties of the 
microorganism(s) 
Part three of the declaration should be extended in order to give stronger 
emphasis also to pathogens of animal and plants, as this is significant in 
environmental risk assessment. These issues are especially impotant to consider 
for in situ bioremediation purposes. 
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Generally, the regulation on declaration and labelling of microbiological products, the 
declaration form and “Guidelines for completing the declaration required according to the 
regulations relating to the declaration and labelling of microbiological products for 
applications that may involve their release to the outdoor environment” focuses on human 
pathogens without giving adequate emphasis to pathogens of animals and plants. The latter 
is significant within ecological context in environmental risk assessment. 
General comments: 
• There seem to be a general lack of accuracy when it comes to specification of what 
microorganisms that are included in the product. Without proper taxonomic 
classification, no meaningful risk assessment is feasible, and the applicant should be 
obliged to name the species and strain(s) in question as specific and accurate as 
possible.  
• There seem to be a lack of emphasis on environmental side effects, especially on 
o the potential for persistence and spread in the environment 
o the potential for pathogenic effects on different wild species (vertebrates, 
arthropods, plants) 
o the potential for pathogenic effects on agricultural plants 
o the marine environment (which should be very important in Norway) 
• There is little emphasis on the effects with increased use and accumulation, 
persistence and spread, both , in terrestrial and aquatic environments. The 
questionnaire should among other things ask about survival ability of the 
microorganisms in question in different types of environment. 
There seem to be a lack of thinking about the potential for disturbance of the ecological 
environment and resulting long-term effects on microbial community. 
Question 13. Has it been reported that the microorganism(s) or other strains of 
the same species have caused disease/injury in humans, animals or plants (name 
of the disease, host organism, disease mechanism) 
Instead of relying on its own, enclosed list of pathogenic organism, the classification of the 
microorganisms in question should be based on well-known public lists (i.e. EU directive 
93/88/EEC, October 1993; NIH Guidelines on Recombinant DNA (April 2002); Canadian 
Laboratory Biosafety Guidelines (2nd ed. 1996); CDC/NIH Biosafety in Microbiological and 
Biomedical Laboratories (4th Edition 1999) or Forskrift om tiltaksverdier og grenseverdier for 
fysiske og kjemiske faktorer i arbeidsmiljøet samt smitterisikogrupper for biologiske faktorer 
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1358#KAPITTEL_9.) However, none of these classifications are based on the environmental 
risk of the microorganisms they deal with, and the reference should preferably be one that in 
addition to assessing risk for human health, also take into account the potential hazard for 
the environment.  
If a microorganism is not listed in any of the recommended sources, or as an alternative to 
relying on such classification lists, other reliable sources may be used. This may be based on 
a literature review of the peer-reviewed scientific literature. If there is any uncertainty 
concerning the risk group the higher group is to be chosen until it has been made clear that 
the risk justifies placement in a lower risk group.  
Not only the pathogenic properties of the actual strain(s) and different strains of the same 
species should be declared, but also species in the same genus and closely related genera, 
should be evaluated. 
If the microorganism is related to any pathogens, it should be declared how the organism in 
the product/product organism differs from any closely related disease causing strains with 
respect to safety:  
• What changes have been made to the organism  to expect that it will not cause 
similar diseases like the related strains;  
• How has the product organism been characterized to ensure it is not a pathogenic 
strain. 
Even for non-pathogens, their ability as opportunistic organisms should be described, e.g. 
against immunocompromised individuals; this can be derived from the published literature. 
Concerning this, if the organism has been shown to cause diseases in immunocompromised 
individuals, a survey of the immune status of individuals in and around the environment of 
application should be conducted to help devise means of mitigating the risk of their infection. 
Knowledge about genetic exchange between the strain in question and other strains and 
species should be asked for (see point 21). 
It should be declared where and in which amounts the microorganism(s) normally are found. 
If it is ubiquitous in the environment, this may indicate lower risk of disease and other 
adverse effects in the environment (see section 13.6). 
The declaration should include documentation of knowledge on 
o acute infectious disease in humans 
o effects of chronic exposure in humans (allergies, sensitization etc.) 
• infectious disease in terrestrial animals 
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• infectious disease in aquatic (including marine) animals 
• effect on insects and other arthropods, especially pollinating insects 
• pathogenic effects on plants 
• effects on microbiological ecology in environments during long-term use and/or use 
of large amounts 
• persistence and accumulation in the environment,  both , soil and aquatic 
The declaration should also state to which degree there is sufficient knowledge on 
occurrence of virulence and resistance factors of the strain that may 
o be exchanged to pathogenic microorganisms 
o cause the current strain to act as an opportunistic pathogen 
It should be stated if there is any knowledge on the bioremediation of complex mixtures. 
The agent should be grouped in a Risk Group (1-4) and the underlying Biosafety Level 
Definition has to be stated, according to e.g. European Economic Community (DIRECTIVE 
93/88/EEC, Oct. 1993), NIH Guidelines on Recombinant DNA (April 2002), Canadian 
Laboratory Biosafety Guidelines (2nd ed. 1996) or CDC/NIH Biosafety in Microbiological and 
Biomedical Laboratories (4th Edition 1999) (see Appendix II). 
Risk Group Databases can be found here: 
1. Forskrift om tiltaksverdier og grenseverdier for fysiske og kjemiske faktorer i 
arbeidsmiljøet samt smitterisikogrupper for biologiske faktorer (forskrift om tiltaks- og 
grenseverdier); Vedlegg 2: Liste over klassifiserte biologiske faktorer (smitterisikogrupper) 
https://lovdata.no/dokument/SF/forskrift/2011-12-06-1358#KAPITTEL_9  
2. American Biological Safety Association https://my.absa.org/tiki-
index.php?page=Riskgroups  
3. Public Health Agency of Canada http://www.phac-aspc.gc.ca/lab-bio/res/psds-
ftss/index-eng.php 
If a microorganism is not listed in any of the recommended sources, other reliable sources 
may be used. There may be a publication in the peer-reviewed scientific literature that 
describes the agent. If there is any uncertainty concerning the risk group the higher group is 
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Question 14. Specify the tests that have been made to ensure that the product is 
not contaminated with unwanted microorganisms, particularly pathogenic 
microorganisms. 
Also here the Panel recommends a revision of the guidelines, especially with emphasis on 
the methodological approach. 
In the guidelines it is stated that “For products consisting solely of identified microorganisms, 
it will be sufficient to test for general contamination”. ‘General contamination’ should be 
clearly defined. Is there contamination by human, animal and plant pathogens? A molecular 
approach should be combined with the culture method given that culture method may be 
unable to detect pathogenic bacteria forms which when they get into the body can 
proliferative and cause diseases. This is especially so for viruses which may be difficult to 
culture without adequate tissue culture and laboratory facilities. A suggestion is to use high-
sensitivity molecular detection to first screen for presence of pathogens, potential pathogens, 
toxin-producing microorganisms and AB resistance genes. Pathogens which cannot be easily 
detected by standard culture methods will therefore be considered further. Also, this 
approach first provides an overview of the pathogens/potential pathogens present, which will 
then guide the culture approach and makes the culture approach more targeted. 
The declaration should provide information about 
• how the quality control and assessment is performed. 
• which procedures that are in place for securing absence of pathogens 
• any testing for known relevant virulence or resistance factors that may increase 
health or environmental risk 
• how the microbial content within the products develops with time through and after 
shelf life. May contamination or other changes occurring during use increase 
virulence?  
The application in our opinion should not necessarily rely on specific methods, as long as the 
methods described are scientifically adequate. A multiphasic approach should be 
emphasized. 
The product needs to be pure before being dispersed to the environment. A pure product will 
ensure adequate characterization of the microorganisms and the eventual breakdown 
product during processing (i.e. before release to the environment). 
Question 15. Specify recommended precautions to be taken in connection with 
use of the product (respiratory equipment, personal protective equipment, 
hygienic measures, etc)  
This section need to be elaborated. In our opinion a declaration should include information 
on:  
• the intended use and instructions for use 
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• special precautions if there are nursing homes, kindergarten or similar in close 
proximity to the bioremediation site.  
• if the product can be used in environments with food production or animal production 
• specific precautions need to be taken with waste, containers etc. 
• specific precautions for use, personal protection  
• storage in relation to how storage influences the microbiological composition and 
pathogenic properties 
10.4 Information on inactivation of microorganisms 
Purpose of Part 4: to determine whether or not the product contains live 
microorganisms. Unless the presence of live microorganisms is important for the 
performance of the product, they should be inactivated. 
 
The Panel considers the guidelines to part 4 to be generally satisfactory in the 
current form, as products for bioremediation must contain live microorganisms. 
Question 16. Does the product contain live microorganisms, including viable 
spores (bacteria and fungi), or cysts (protozoans)?  
If the product contains organisms that form endospores, spores or cysts, procedures for 
activating the spores or cysts and for further cultivation should be described.  
10.5 Information on where and how the product is to be used 
Purpose of Part 5: to obtain information that gives an indication of the risk of 
unwanted establishment and dispersion of the microorganism in the environment 
in which the product is intended for use. 
The Panel recommends that the guidelines are extended for part 5. The Panel 
especially suggests more emphasis concerning possible hazards for particular risk 
groups and clarification on the where and how the products should be used or 
should not be used. Possible short or long term impacts for the environment, and 
methods for inactivation or for sanitary quarantine of the contaminated area 
when used unintentionally should be discussed.  
Question 17. Where is the product intended to be used, and is this environment 
appreciably different from the environment from which the microorganisms have 
been isolated? 
Since the main focus of part 5 is to obtain information on unintended effects, it would be 
necessary to state likely environments (different from the environment of exposure) which 
can also inadvertently exposed to the product and in which the microorganisms can thrive. It 
will be necessary to describe similarities between the intended and these likely-to-be 
exposed unintended environments; measures on how the product(s) will be excluded from 
these environments should be clearly stated. 
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The risks linked to the use of strains which belong to species known to include opportunistic 
pathogens and possible hazards for particular risk groups (YOPI – young, old, pregnant, 
immune compromised) should be clarified; this is linked to possible restrictions in areas in 
close proximity to e.g. hospitals, retirement homes, and child care. 
Question 18. How are the microorganisms released to the environment? 
Even if notifiers provide information supporting the exposure assessment for the 
microorganism, models for predicting environmental fate or expression are lacking. 
It should be discussed what kinds of shift in the microbial community and local community 
can be expected in the receiving environment, especially if exposure is chronic and frequent. 
It seems it has been taken for granted that the form of the organism to be released 
(spores/endospores/cysts/live vegetative cells) will also inform the type of method to be 
used in the release.  Given that companies provide only requested information ignoring 
information not explicitly requested, it might be necessary to also state that the form of the 
organism to be released and the method of spread that is adopted.  
Question 19. With respect to the microorganisms, what are the typical 
concentrations, quantities (quantity per unit of volume, weight or area) and 
frequencies of application, and the total number of applications? 
Data on the persistence of vegetative forms and spores in the environment should be 
provided, and conditions for germination of the latter should be described. 
Prescriptions related to further application of the product need to be provided. Particular 
attention should be given in case the microorganism establishes itself in the environment 
(sporulation). 
To help predicting how the existing ecosystem will be affected by introduction of the product 
information on the colonization ability (including competitive ability in relation to closely 
related species) in the new environment should be provided.   
10.6 Description of the microorganism 
Purpose of Part 6: to obtain information on any traits of the microorganisms that 
have a strong bearing on the risk of injury to health or environmental damage. 
The Panel suggest that this part is revised. Some specific considerations are discussed 
below. 
 “Environmental Damage” is not sufficiently/explicitly defined. The declaration form focuses 
only on the introduction of foreign gene into the ecosystem. The environment can also be 
permanently altered (or damaged) if the introduction of the new organisms results in the 
extinction of the naturally existing closely related species (see also comment on Question 
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19). How the metabolic by-product arising from the bioremediation alters, for example, pH, 
alkalinity/acidity, etc., and how they affect resident microbial communities could be a 
necessary information too. 
Question 20. Have the microorganisms been deliberately altered since their 
isolation, and if so how?  
The effect of the alteration on the genetic makeup and physiology of the organisms should 
also be determined; e.g. a comparison with the isogenic parental wildtype at genomic and 
physiological (proteomic and metabolomics levels) 
Although this document emphasizes deliberate alteration, non-deliberate (unexpected 
alteration) should also be determined, for example, after the isolate would have been 
passaged several times. In such cases the strains current environment (laboratory or Culture 
center) will be quite different from the original environment of isolation. Information such as 
passage number and duration of storage in the Culture Collection Centre will be useful. 
Therefore, information on how the Master Seed Culture and Working Cultures are maintained 
is necessary. 
Question 21. For products containing bacteria: what pattern of resistance do they 
show to antibiotics (including synthetic antibacterial agents)? 
Rather than specifying a list of specific antibiotics employ generic classes of antibiotics. The 
latter seems more adaptable to new emergent antibiotics and are well suited to (if 
necessary) rank the risk for antibiotic resistance based on resistance patterns / mechanisms 
(some of which may be transferable). It could e.g. be specified that the microorganisms 
cannot show antibiotic resistance to aminoglycosides, macrolides, Beta-lactam, tetracyclines, 
fluoroquinolones or other quinolones according to EUCAST or Nordic AST or other equivalent 
method. This is a disk diffusion method (Nordic AST refers to EUCAST). For comparison, the 
Norwegian legislation asks for resistance against amoxicillin/clavulanic acid, ampicillin, 
cephalothin, chloramphenicol, erythromycin, fucidic acid, lincomycin, methicillin, norfloxacin, 
oxytetracycline, penicillin, trimethoprime/sulfamethoxazole and vancomycin.   
Question 22. Do the microorganisms have special survival mechanisms, for 
example the formation of spores in bacteria? 
Some microorganisms form survival and dispersal structures. These are called endospores in 
bacteria, spores and conidia in fungi and cysts in protozoans (though the term spores is 
often used for protozoans as well). Adverse environmental conditions often trigger the 
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10.7 Ecological effects related to degradation processes 
Purpose of Part 7: to obtain information on any environmental effects of the 
product, with special emphasis on the formation of harmful intermediate 
products during the degradation process. 
Question 23. Give a brief description of metabolic pathways for the degradation 
of the pollutants in question or, if appropriate, of similar compounds 
We consider that these issues are well covered by existing regulations. We have no further 
comments to this question. 
Question 24. Does the degradation process involve the formation of stable 
intermediate products with different and/or environmentally more harmful 
properties than the original compounds (toxicity, biodegradability, 
bioaccumulation potential, solubility in water, carcinogenicity)? Specify the 
chemical identity of any environmentally harmful intermediate products. 
A comprehensive list of suggested tests is provided in the guidelines. However, in general 
such lists are in danger of being obsolete and consequently must be updated on a regular 
basis. In order to avoid this, we suggest a more general formulation, as e.g.: If a literature 
review does not provide adequate documentation, standard tests generally accepted as the 
currently best tests for the purpose (e.g. OECD/ISO tests) are recommended as a starting 
point for answering question 23 and 24. Even if such tests are carried out under conditions 
which may be significantly different from natural environmental conditions, they will give a 
good indication of whether harmful intermediate compounds are formed. Appropriate tests 
should be selected on the basis of whether the product is to be used in a fresh-water, 
marine or terrestrial (soil) environment. The rationale for the use of the selected test should 
be given. 
Documentation may also be obtained by means of simulated environmental studies. 
However, a satisfactory simulation study can constitute an entire research project in itself, 
and often requires extensive resources.” 
Given that the pollutants could be complex mixtures, as noted in the guidelines for question 
23 it will be difficult for applicants to specify the chemical identity of any environmentally 
harmful intermediate products. Another alternative will also be to change “any 
environmentally harmful intermediate products to “main environmentally harmful 
intermediate products”. 
Question 25. Can the product have undesirable effects on important natural 
microbial processes in the environment, for example nitrogen/phosphorus cycles 
and carbon mineralization, or by altering pH or oxygen concentration?  
Biological functions usually are extremely specific Bioremediation could consequently disturb 
the ecosystem. In order for the correct microbes to be present, the appropriate 
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environmental conditions, levels of nutrients, and contaminants need to be met. As an 
example very low (<3) and very high (>9) pH values or sudden changes in pH can 
significantly inhibit microbial growth, gas solubility in soil water, nutrients availability and 
solubility of heavy metals (Mohee and Mudhoo, 2012). The availability and/or toxicity of 
metals necessary (often in trace amounts) for plants and microbes is usually dependent on 
pH and metals are generally becoming more mobile/available at higher pH values.  
Information on possible physiological and biochemical ecological changes and the prediction 
of the development of natural microbial communities (resistant to change, resilient or 
development of new but functionally similar communites) is consequently valuable (Allison 
and Martiny, 2008).  However, given the complexity, is it difficult to provide a complete 
overview of possible undesirable effects on important natural microbial processes in the 
environment. Consequently, we consider that these issues are well covered by existing 
regulations and have no further comments to this question.   
10.8 Other relevant information 
Question 26. Give any other information in the form of empirical or test data that 
is relevant to the hazard to health or the environment posed by use of the 
microbiological product, and to which the importer/manufacturer has or should 
have access. 
We consider that these issues are well covered by existing regulations and have no further 
comments to this question. 
10.9 Overall assessment of risk to human health and the 
environment 
Question 27 Give an overall assessment of the risk to human health and the 
environment posed by use of the product.  
 
The guidelines here are very open and general.  Specific guidelines should be provided on 
how this should be done, as for instance demand simple risk assessment diagrams. 
 
The question should be more specified. A risk assessment should be given for: 
1) Health hazards caused by microorganisms in the product 
a) Intended use of the product 
b) Wrong (unintended) use of the product 
2) Environmental hazards caused by microorganisms in the product 
a) Intended use of the product 
b) Wrong (unintended) use of the product 
3) Health hazards caused by chemicals in the product  
a) Intended use of the product 
b) Wrong (unintended) use of the product 
4) Environmental hazards caused by chemicals in the product 
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a) Intended use of the product 
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11 Uncertainties  
For the purpose of clarity and transparency in risk assessment processes, it is recommended 
that assessments identify areas of uncertainties and state clearly their subsequent impact on 
the overall assessment outcome since this is critical in subsequent selection of risk 
management options (EFSA draft opinion). 
Most of the work done on bioremediation of most compounds are lab experiments or in situ 
pilot experiments. There is therefore limited data from full field-scale bioremediation systems 
for specified sources of uncertainty to be iterated. 
The interactions between even a well-described microorganism and the biotic and abiotic 
environment they are released into are complex. Taking also into consideration the inherent 
lability of biological systems, there will always be considerable uncertainty about the long-
term impact on health and environment regarding the use of microorganisms in remediation.  
The long-term effects of bioremediation is uncertain due to the risk of evolution of 
pathogenicity in microbes that are continuously exposed to the environment. 
Generally, the degree of uncertainty regarding the effects of increased use of bioremediation 
might have on health and environment, inherently has to be high. This uncertainty is partly 
related to the dearth of scientific research on adverse effects of the application of 
bioremediation in the Norwegian environment, but even if these knowledge gaps (see 
section 13) were filled before microorganisms are introduced into a complex ecosystem 
(including the wide variety of human behaviour into the concept of “ecosystem”), uncertainty 
of potential impacts on health and environment may still prevail.  
Notably, decisions will have to be made ahead of conclusive scientific evidence accordingly. 
However, the resulting ambiguity of a mixture of scientific knowledge and non-objective 
assumptions may be acceptable to the public if the processes and decisions are made open 
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12 Conclusions (with answers to the 
terms of reference) 
 
This report is divided into two main parts according to the assignment given by The 
Norwegian Environment Agency.  
 
The first part is an overview of bioremediation of polluted ground based on bioaugmentation 
described in literature for the degradation of various types of pollutants including 
hydrocarbons, heavy metals, chlorinated compounds, and explosives. The most common 
microbial classes with regards to properties relevant for environmental and health risk 
assessment (e.g. spore formation, survival, proliferation, and pathogenicity) are described. 
 
Based on scientific assessment of the information requirements laid down in the declaration 
form of the Regulation of Microbial products, VKM concludes that the information 
requirements in their current form are not sufficient to conduct a health and environmental 
risk assessment of added microorganisms for bioremediation of polluted ground in Norway. 
 
Consequently, VKM has suggested updated information requirements that producers and 
importers must / should meet that can be used as a basis for the risk assessment of health 
and environmental risks associated with added microorganisms for bioremediation of 
polluted ground. Both general requirements and more specific requirements are suggested.  
The proposed information requirements can be obtained using internationally recognized 
methods available today.  
 
On the subject matter regarding the evaluation of whether there is sufficient knowledge to 
carry out risk assessments of added microorganisms in bioremediation in Norway, the VKM 
Panel is of the opinion that critical knowledge gaps exists. Specific knowledge on the 
microorganisms intended for usage for remediation purposes in Norway (including gene 
characteristics) and their performance and interactions in the environment is needed to 
perform risk assessments.  
Assessment of genetically modified microorganisms (GMO) is not included as these are 
regulated under other legislation and procedures. In compliance with the assignment are 
phytoremediation, bioremediation based on natural attenuation and bio-stimulation or 
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13 Data gaps  
Notably, the working group did not evaluate declaration forms regarding specific products on 
the Norwegian market and the extent of usage. Iterated below are data gaps identified in 
literature: 
• There is no information on the ecological impact of the transient biodegradation 
intermediates of PAH degradation. 
• The intermediate products of the slow anaerobic PAH biodegradation will persist long 
in the environment. Information on the impact of these on the environment is 
lacking. 
• Most of the work done on bioremediation of nitro-aromatic compounds are lab 
experiments or in situ pilot experiments. Data are lacking from full field-scale 
bioremediation systems. 
• Work done on aerobic bioremediation of halo-organics is scarce. Similar to nitro-
aromatics, most of the published work has been performed in small-scale 
environments.  
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15 Appendix I 
Table 1. Microbes reported to perform biodegenerating effects 





















Acidovorax  x  x     
Acinetobacter    x   x 
Actinomycete   x     
Alcaligenes      x    
Arthrobacter   x x     
Bacillus    x     
Burkholderia   x    x   
Comamonas  x x       
Enterobacter        x 
Hydrogenophaga       x   
Klebsiella    x   x 
Moraxella    x     
Mycobacterium         
Nocardiodes    x   x 
Pseudomonas x x x   x x 
Ralstonia  x x x x     
Rhizobium        x 
Rhodococcus    x   x 









ia Clostridium        x 
Desulfovibrio  x     x x 
Desulphatomaculem   x     
Haloanaerobicum  x  x x    
Methanobacterium    x     
Methylobacterium        x 




Candida x        
Heterobasidium        x 
Hypholoma         x 
Nematoloma       x 
Phanerochaete    x  x x 
Phlebia        x 
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16 Appendix II 
European Economic Community (DIRECTIVE 93/88/EEC, Oct. 
1993), NIH Guidelines on Recombinant DNA (April 2002), 
Canadian Laboratory Biosafety Guidelines (2nd ed. 1996) and 
CDC/NIH Biosafety in Microbiological and Biomedical 
Laboratories (4th Edition 1999) 
European Economic Community (DIRECTIVE 93/88/EEC, Oct. 1993) 
(1) Group 1 biological agent means one that is unlikely to cause human disease; 
(2) Group 2 biological agent means one that can cause human disease and might be a 
hazard to workers; it is unlikely to spread to the community; there is usually effective 
prophylaxis or treatment available; 
(3) Group 3 biological agent means one that can cause severe human disease and present a 
serious hazard to workers; it may present a risk of spreading to the community, but there is 
usually effective prophylaxis or treatment available; 
(4) Group 4 biological agent means one that causes severe human disease and is a serious 
hazard to workers; it may present a high risk of spreading to the community; there is usually 
no effective prophylaxis or treatment available. 
NIH Guidelines on Recombinant DNA (April 2002) 
(1) Risk Group 1 (RG1) agents are not associated with disease in healthy adult humans. 
(2) Risk Group 2 (RG2) agents are associated with human disease which is rarely serious and 
for which preventive or therapeutic interventions are often available. 
(3) Risk Group 3 (RG3) agents are associated with serious or lethal human disease for which 
preventive or therapeutic interventions may be available. 
(4) Risk Group 4 (RG4) agents are likely to cause serious or lethal human disease for which 
preventive or therapeutic interventions are not usually available. 
Canadian Laboratory Biosafety Guidelines (2nd ed. 1996) 
(1) Risk Group 1 (low individual and community risk) This group includes those 
microorganisms, bacteria, fungi, viruses and parasites, which are unlikely to cause disease in 
healthy workers or animals 
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(2) Risk Group 2 (moderate individual risk, limited community risk) A pathogen that can 
cause human or animal disease but under normal circumstances, is unlikely to be a serious 
hazard to healthy laboratory workers, the community, livestock, or the environment. 
Laboratory exposures rarely cause infection leading to serious disease; effective treatment 
and preventive measures are available and the risk of spread is limited. 
(3) Risk Group 3 (high individual risk, low community risk) A pathogen that usually causes 
serious human or animal disease, or which can result in serious economic consequences but 
does not ordinarily spread by casual contact from one individual to another, or that can be 
treated by antimicrobial or anti-parasitic agents. 
(4) Risk Group 4 (high individual risk, high community risk) A pathogen that usually produces 
very serious human animal disease, often untreatable, and may be readily transmitted from 
one individual to another, or from animal to human or vice-versa directly or indirectly, or 
casual contact. 
CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (4th Edition 
1999) 
(1) BIOSAFETY 1 is suitable for work involving well-characterized agents not known to cause 
disease in healthy adult humans, and of minimal potential hazard to laboratory personnel 
and the environment. 
(2) BIOSAFETY LEVEL 2 is similar to Level 1 and is suitable for work involving agents of 
moderate potential hazard to personnel and the environment.  
(3) BIOSAFETY LEVEL 3 is applicable to clinical, diagnostic, teaching, research, or production 
facilities in which work is done with indigenous or exotic agents which may cause serious or 
potentially lethal disease as a result of exposure by the inhalation route. 
(4) BIOSAFETY LEVEL 4 is required for work with dangerous and exotic agents which pose a 
high individual risk of aerosol-transmitted laboratory infections and life-threatening disease. 
 
